Loading news...
Loading news...
Series B funding round for Obsidian Therapeutics raising $120M in September 2021
Series B funding round for Obsidian Therapeutics raising $120M in September 2021
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
The Column GroupLEAD | Venture Capital | — |
| Private | — | |
| Private | — | |
| Private | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$330.5M
Top Valuation
-
Obsidian Therapeutics raised $120M in a Series B round.
The round was announced on 09/01/21.
The round was led by The Column Group.